Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy

NCT04026178 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Lipodystrophy

Interventions

DRUG: Metreleptin

Sponsor

Aegerion Pharmaceuticals, Inc.